ATE137975T1 - Amylin zur behandlung von knochenleiden - Google Patents

Amylin zur behandlung von knochenleiden

Info

Publication number
ATE137975T1
ATE137975T1 AT90307471T AT90307471T ATE137975T1 AT E137975 T1 ATE137975 T1 AT E137975T1 AT 90307471 T AT90307471 T AT 90307471T AT 90307471 T AT90307471 T AT 90307471T AT E137975 T1 ATE137975 T1 AT E137975T1
Authority
AT
Austria
Prior art keywords
amylin
bone
treatment
disorders
variants
Prior art date
Application number
AT90307471T
Other languages
English (en)
Inventor
Iain Macintyre
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE137975T1 publication Critical patent/ATE137975T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
AT90307471T 1989-07-08 1990-07-09 Amylin zur behandlung von knochenleiden ATE137975T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898915712A GB8915712D0 (en) 1989-07-08 1989-07-08 Medical treatment

Publications (1)

Publication Number Publication Date
ATE137975T1 true ATE137975T1 (de) 1996-06-15

Family

ID=10659773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90307471T ATE137975T1 (de) 1989-07-08 1990-07-09 Amylin zur behandlung von knochenleiden

Country Status (12)

Country Link
EP (1) EP0408284B1 (de)
JP (1) JPH04500691A (de)
AT (1) ATE137975T1 (de)
CA (1) CA2020752C (de)
DE (1) DE69026986T2 (de)
DK (2) DK0408284T3 (de)
ES (1) ES2088971T3 (de)
GB (1) GB8915712D0 (de)
GR (1) GR3020680T3 (de)
IE (1) IE62625B1 (de)
SG (1) SG46382A1 (de)
WO (1) WO1991000710A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG49239A1 (en) * 1991-05-24 1998-05-18 Amylin Pharmaceuticals Inc Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
EP0586592B1 (de) * 1991-05-24 2000-11-29 Amylin Pharmaceuticals, Inc. Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE287390T1 (de) 1994-10-21 2005-02-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
ATE430123T1 (de) 1996-05-01 2009-05-15 Nps Pharma Inc Inorganische am ionen-rezeptor aktive verbindungen
US6869926B1 (en) 1997-09-26 2005-03-22 Auckland Uniservices Limited Therapeutic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
GB8407907D0 (en) * 1984-03-27 1984-05-02 Sandoz Ltd Organic compounds
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
JPS62129297A (ja) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd カルシトニン遺伝子関連ペプチド誘導体
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
HU203198B (en) * 1987-10-26 1991-06-28 Sandoz Ag Process for producing pharmaceutical compositions having immunity-inhibiting, monokin-, particularly interleukin-1-inhibiting effect
JP2944117B2 (ja) * 1988-07-22 1999-08-30 エチル・コーポレーション 骨の処置におけるケイ素化合物

Also Published As

Publication number Publication date
GB8915712D0 (en) 1989-08-31
GR3020680T3 (en) 1996-10-31
SG46382A1 (en) 1998-02-20
IE902494A1 (en) 1991-02-13
CA2020752A1 (en) 1992-01-10
EP0408284B1 (de) 1996-05-15
ES2088971T3 (es) 1996-10-01
DK0408284T3 (da) 1996-06-03
DK40191D0 (da) 1991-03-07
CA2020752C (en) 1996-12-24
IE62625B1 (en) 1995-02-22
EP0408284A3 (en) 1992-01-08
DE69026986D1 (de) 1996-06-20
WO1991000710A1 (en) 1991-01-24
DK40191A (da) 1991-03-07
DE69026986T2 (de) 1996-10-02
JPH04500691A (ja) 1992-02-06
EP0408284A2 (de) 1991-01-16

Similar Documents

Publication Publication Date Title
DE69026986T2 (de) Amylin zur Behandlung von Knochenleiden
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
IS2132B (is) Notkun á estrogeni til framleiðslu á lyfi til meðhöndlunar vegna tíðahvarfa
ATE111331T1 (de) Schiene zur behandlung der fraktur von colles.
DK408089D0 (da) Proteiner
AU1808488A (en) Compounds for the treatment of alzheimer's disease
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
GB2193102B (en) Fracture brace
GB8621816D0 (en) Therapeutic composition
JPS6471889A (en) Novel 6-acyl-(6h)-dibenzo(c,e)(1,2)oxaphosphorine- 6-oxide, manufacture and use as photoinitiator
DE69010294T2 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
FI971127A (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
HU9301726D0 (en) Compounds and preparatives hindering resorption of bones
DE3855159D1 (de) Thienotricyclen zur Behandlung von Erkrankungen der Bronchien
EP0493737A3 (de) Einen basischen Fibroblastwachstumsfaktor enthaltende Mittel zur Behandlung von Knochenkrankheiten
EP0295827A3 (de) Verwendung von 24,25-Dihydroxycholecalciferol bei der Heilung von Knochenbrüchen
NZ221473A (en) Octapeptide somatostatin analogue "octreotide" in nasal compositions
GR860897B (en) Woman's heel
ATE72979T1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time